Retrieved from Lund University's publications database
- Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease
- Plasma stem cell factor levels are associated with risk of cardiovascular disease and death
- Recent advances on CD4<sup>+</sup> T cells in atherosclerosis and its implications for therapy
- Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair Processes.
- Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes
- CD4(+) CD56(+) natural killer T-like cells secreting interferon-γ are associated with incident coronary events.
- Decreased levels of stem cell factor in subjects with incident coronary events.
- Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE<sup>-/-</sup> mice
- Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
- High Plasma Levels of Heparin-Binding Epidermal Growth Factor Are Associated With a More Stable Plaque Phenotype and Reduced Incidence of Coronary Events.
- IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice.
- Nuclear Factor of Activated T Cells Is Activated in the Endothelium of Retinal Microvessels in Diabetic Mice.
- Pathogenic immunity in systemic lupus erythematous and atherosclerosis: common mechanisms and possible targets for intervention.
- Apob-100 Peptide Immunization Reduce Macrophage Plaque Infiltration In Apobec1-/- Ldlr-/- Mice With Advanced Atherosclerotic Lesions
- Atheroprotective Effects of Alum Are Associated With Capture of Oxidized LDL Antigens and Activation of Regulatory T Cells.
- Evidence Of A Role Of T Regulatory Cells Mediating Atheroprotection By APO B 100 Peptide Immunization
- Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.
20 October 2016